Share this post on:

S inpatients were collected using a convenient sampling approach. A priory power analysis showed that a sample size of 10 to 15 per group would be sufficient for detecting differences in trace element levels in the aqueous humor (power 80 , significance level 5 ). Of a total of 90 patients undergoing surgery in december of 2010, 12 patients with dry AMD fulfilled the inclusion criteria (age 77.9 years; SD: 6.6; 8 females, 4 males), and 11 patients without AMD (age 66.6 years; SD: 16.7, female 7, male 4) were 25033180 matched to these patients. All participants were of Caucasian race. All controls and patients were thoroughly examined by slit lamp inspection, applanation tonometry, fundoscopy, and gonioscopy. Criteria for AMD diagnosis were the presence of drusen and/or irregularities of retinal pigment epithelial cells. However, patients with signs of exsudative AMD were excluded. Controls (cataracts) had no signs of AMD. In order to match the groups as closely as possible, a detailed medical history was obtained and controls were matched to cases by demographic, clinical, nutritional and lifestyle data known to affect trace element levels. Nutritional and lifestyle status were briefly assessed using the SGNA-test (subjective global nutritional assessment-test). Patients with hypovitaminoses were excluded (data not shown), so that all participants (AMD patients and controls) were classified as well-nourished. Exclusion criteria were: medical history of major systemic illness (vasculitis, renal and hepatic disease), gastrointestinal malabsorption, psychiatric illness, hypothyroidism, severe psoriasis, malignant neoplasias, evidence of chronic alcohol abuse during the past half year, cigarette smoking, as well prior ocular surgery, a history of ocular K162 chemical information inflammation, diabetic retinopathy, myopia, retinal occlusive disease, and rubeosis iridis. We excluded patients taking vitamin supplements or other medications which affect trace element concentrations, such as fibrates, carbamazepine, phenytoin and antifolates (methotrexate and trimethoprim). Demographical data, medical history and systemic medication are summarized in tables 1 and 2. Age and gender as potentially confounding factors were accounted for by inclusion in the general linear model.Co : y 11:03xz310:Cu : y 7167:7x{7198:Fe : y 375:3x{3419:Hg : y 3:157x{29:Mn : y 19:317xz180:Pb : y 19:527xz987:Se : y 1:0568xz6:Zn : y 2120:7xz12803 Triplicate measurements were performed for each sample. For quality control, standard solutions and blanks were measured periodically between the Verubecestat web samples. Data processing of FI-ICP-MSTrace Elements in AMDTable 1. Demographical data and medical history of patients in the AMD and the control group.AMD group No. of patients Age (years) Male:female General Medical History Arterial hypertension (no. of patients) Coronary artery disease Cardiac arrythmia Hyperlipidemia Hyperuricemia Diabetes mellitus Struma Osteoporosis Others (asthma, hirsutism, arthrosis, depression, menopause, COPD, peripheral arterial disease) doi:10.1371/journal.pone.0056734.t001 8 2 1 3 1 2 1 2 5 12 77.966.62 8:Control group 11 66.6616.7 7:7 2 2 3 2 1 3 1signals was accomplished by exporting the element data files from the ICP-MS control software and integrating FI-element peaks with the Knauer HPLC software “Clarity”.adjusted using a Bonferroni correction. Statistical analyses were performed using InStat (GraphPad Software, Inc. CA, USA) and PASW Statistics 18 (IBM, Somers, NY, USA).Statistica.S inpatients were collected using a convenient sampling approach. A priory power analysis showed that a sample size of 10 to 15 per group would be sufficient for detecting differences in trace element levels in the aqueous humor (power 80 , significance level 5 ). Of a total of 90 patients undergoing surgery in december of 2010, 12 patients with dry AMD fulfilled the inclusion criteria (age 77.9 years; SD: 6.6; 8 females, 4 males), and 11 patients without AMD (age 66.6 years; SD: 16.7, female 7, male 4) were 25033180 matched to these patients. All participants were of Caucasian race. All controls and patients were thoroughly examined by slit lamp inspection, applanation tonometry, fundoscopy, and gonioscopy. Criteria for AMD diagnosis were the presence of drusen and/or irregularities of retinal pigment epithelial cells. However, patients with signs of exsudative AMD were excluded. Controls (cataracts) had no signs of AMD. In order to match the groups as closely as possible, a detailed medical history was obtained and controls were matched to cases by demographic, clinical, nutritional and lifestyle data known to affect trace element levels. Nutritional and lifestyle status were briefly assessed using the SGNA-test (subjective global nutritional assessment-test). Patients with hypovitaminoses were excluded (data not shown), so that all participants (AMD patients and controls) were classified as well-nourished. Exclusion criteria were: medical history of major systemic illness (vasculitis, renal and hepatic disease), gastrointestinal malabsorption, psychiatric illness, hypothyroidism, severe psoriasis, malignant neoplasias, evidence of chronic alcohol abuse during the past half year, cigarette smoking, as well prior ocular surgery, a history of ocular inflammation, diabetic retinopathy, myopia, retinal occlusive disease, and rubeosis iridis. We excluded patients taking vitamin supplements or other medications which affect trace element concentrations, such as fibrates, carbamazepine, phenytoin and antifolates (methotrexate and trimethoprim). Demographical data, medical history and systemic medication are summarized in tables 1 and 2. Age and gender as potentially confounding factors were accounted for by inclusion in the general linear model.Co : y 11:03xz310:Cu : y 7167:7x{7198:Fe : y 375:3x{3419:Hg : y 3:157x{29:Mn : y 19:317xz180:Pb : y 19:527xz987:Se : y 1:0568xz6:Zn : y 2120:7xz12803 Triplicate measurements were performed for each sample. For quality control, standard solutions and blanks were measured periodically between the samples. Data processing of FI-ICP-MSTrace Elements in AMDTable 1. Demographical data and medical history of patients in the AMD and the control group.AMD group No. of patients Age (years) Male:female General Medical History Arterial hypertension (no. of patients) Coronary artery disease Cardiac arrythmia Hyperlipidemia Hyperuricemia Diabetes mellitus Struma Osteoporosis Others (asthma, hirsutism, arthrosis, depression, menopause, COPD, peripheral arterial disease) doi:10.1371/journal.pone.0056734.t001 8 2 1 3 1 2 1 2 5 12 77.966.62 8:Control group 11 66.6616.7 7:7 2 2 3 2 1 3 1signals was accomplished by exporting the element data files from the ICP-MS control software and integrating FI-element peaks with the Knauer HPLC software “Clarity”.adjusted using a Bonferroni correction. Statistical analyses were performed using InStat (GraphPad Software, Inc. CA, USA) and PASW Statistics 18 (IBM, Somers, NY, USA).Statistica.

Share this post on: